Aurora Spine Corporation
ASAPF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.51 | 0.30 | 0.01 | -0.39 |
| FCF Yield | 0.86% | -1.86% | 0.84% | 2.77% |
| EV / EBITDA | 163.30 | -573.84 | -69.31 | 54.24 |
| Quality | ||||
| ROIC | -1.72% | -3.36% | -5.48% | 1.31% |
| Gross Margin | 62.24% | 58.02% | 23.24% | 60.47% |
| Cash Conversion Ratio | -1.01 | 0.46 | -0.28 | 7.29 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.81% | 7.68% | 5.38% | 6.10% |
| Free Cash Flow Growth | 141.33% | -294.37% | -59.50% | 127.16% |
| Safety | ||||
| Net Debt / EBITDA | 24.82 | -82.12 | -5.15 | 8.01 |
| Interest Coverage | -3.09 | -6.24 | -10.18 | 2.64 |
| Efficiency | ||||
| Inventory Turnover | 0.44 | 0.49 | 0.55 | 0.51 |
| Cash Conversion Cycle | 174.23 | 168.62 | 158.43 | 170.08 |